Search results
Results from the Tech24 Deals Content Network
Shares of 23andMe are now priced at about $0.70, and in November the company was informed that it was in violation of Nasdaq rules that require a company to maintain a stock price above $1. That ...
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] [2] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [3] to generate reports relating to the customer's ancestry and ...
Genetic database builder 23andMe (NASDAQ: ME) stock slid 10% through 12:05 p.m. ET Tuesday. Curiously, though, the news that 23andMe reported today seemed generally of the "good" variety. The ...
DNA testing technology company 23andMe has raised just shy of $82.5 million in new funding, from an offering of $85 million in total equity shares, according to a new SEC filing. The funding ...
The Nasdaq Composite ( ticker symbol ^IXIC) [ 2] is a stock market index that includes almost all stocks listed on the Nasdaq stock exchange. Along with the Dow Jones Industrial Average and S&P 500, it is one of the three most-followed stock market indices in the United States. The composition of the NASDAQ Composite is heavily weighted towards ...
Anne Wojcicki. Anne E. Wojcicki ( / wuːˈtʃɪtski / woo-CHITS-kee; [ 2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize .
Comment. Following up on the news of 23andMe’s huge upcoming financing round, TechCrunch has learned that the company is raising the new financing at a $1.5 billion pre-money valuation. This ...
widdowquinn/Flickr. DNA testing company 23andMe has partnered with pharmaceutical giant GlaxoSmithKline (GSK), in a bid to develop new drug treatments. 23andMe, which gives customers insight into ...